| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |